FindTrial
Sign In

Prevalence of neuropathic pain and its effect on quality of life of cancer patients attending palliative care unit and oncology wards.

COMPARATIVE EVALUATION OF CHARACTERISTICS OF NEUROPATHIC PAIN AND ITS EFFECT ON QUALITY OF LIFE IN CANCER PATIENTS IN ONCOLOGY WARD AND PALLIATIVE CARE UNIT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022457
Enrollment
160
Registered
2019-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

vardman mahavir medical college and safdarjung hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed with cancer and presenting with pain and a willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Patients with Mental disability leading to language and cognitive impairment, Diagnosed neuropathy of non-cancer causes and receiving treatment for the same, Intensive care and emergency care.

Design outcomes

Primary

MeasureTime frame
To assess neuropathic pain in cancer patients treated in oncology ward and palliative care unit by Short Form â?? Brief Pain Inventory (SF-BPI) and The Self Complete Leeds Assessment of Neuropathic Symptoms and Signs Scale (S-LANSS) and its effect on quality of life by The Edmonton Symptom Assessment System and The ECOG scale.Timepoint: at the time of admission—

Secondary

MeasureTime frame
factors like Psychological, Social, Physical health, Environmental affecting the quality of life in cancer patients using WHOQOL-BREF scaleTimepoint: at the time of admission—

Countries

India

Contacts

Public ContactDr Madhu Dayal

vardhman mahavir medical college and safdarjung hospital

drmadhudayal@gmail.com9566293149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026